Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High expression of Inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia

30 Jan 2015

Abstract excerpt

// Jin-long Shi 1, * , Lin Fu 2, * , Wei-dong Wang 1 1 Medical Engineering Support Center, Chinese PLA General Hospital, Beijing 100853, China 2 Department of Hematology and Lymphoma Research Center, Peking University, Beijing 100191, China * These authors have contributed equally to this work Correspondence to: Wei-dong Wang, e-mail: wangwd301@126.com Keywords: ITPR2 , expression, prognostic biomarker,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25779662
DOI: 10.18632/oncotarget.3024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High expression of Inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemiaPMID 25779662Read ↗

Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalitiesSemantic proximity Read ↗

INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.Semantic proximity Read ↗

A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genesSemantic proximity Read ↗

Analysis of the differential expression and prognostic relationship of DEGs in AML based on TCGA databaseSemantic proximity Read ↗

Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia.Semantic proximity Read ↗

An mRNA expression signature for prognostication inde novoacute myeloid leukemia patients with normal karyotypeSemantic proximity Read ↗

PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid LeukemiaSemantic proximity Read ↗

Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid CancersSemantic proximity Read ↗

Identification of Novel Genes Implicated in Acute Myeloid Leukemia Progression using Bioinformatics Analysis of Microarray DataSemantic proximity Read ↗

Identification and validation of a prognostic Risk-Scoring Model based on LATS2 expression in acute myeloid leukemiaSemantic proximity Read ↗

Pan-cancer analysis revealing that PTPN2 is a indicator of risk stratification for acute myeloid leukemia identification of high-risk patientsSemantic proximity Read ↗

ITGB2 Expression is Negatively Correlated with the Prognosis of Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.